InvestorsHub Logo
Followers 3
Posts 965
Boards Moderated 0
Alias Born 02/07/2016

Re: None

Monday, 08/24/2020 3:47:28 PM

Monday, August 24, 2020 3:47:28 PM

Post# of 9130
Regeneron and Roche Collaborate to Significantly Increase Global Supply of REGN-COV2 Investigational Antibody Cocktail for COVID-19

REGN-COV2 is given IV. “REGN-COV2 is currently being studied in two Phase 2/3 clinical trials for the treatment of COVID-19 and in a Phase 3 trial for the prevention of COVID-19 in household contacts of infected individuals. If it proves safe and effective in clinical trials and regulatory approvals are granted, Regeneron will distribute and record sales for REGN-COV2 in the U.S. and Roche will be responsible for distribution outside the U.S.”


https://www.prnewswire.com/news-releases/regeneron-and-roche-collaborate-to-significantly-increase-global-supply-of-regn-cov2-investigational-antibody-cocktail-for-covid-19-301114443.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent HALO News